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Résumé en
anglais
ObjectiveTo study the efficacy and safety of intrathecal baclofen therapy (ITB) in
wheelchair-dependent adults with cerebral palsy. Patients and methods A
retrospective analysis and clinical examination of 25 wheelchair-assisted adults
with cerebral palsy receiving ITB initiated between 1999 and 2009 in three
different cities in western France. Results ITB improves spasticity and facilitates
wheelchair comfort and nursing care. The therapy has an effect on motor disorders
and pain. Eighty percent of the ITB patients were satisfied. Dissatisfaction was
related to complications or adverse events and not lack of efficacy. Complications
occurred in 32% of the patients and transient interruption of the treatment or
surgical removal of the ITB pump was necessary in 16% of cases. Discussion and
conclusion Wider use of ITB in this indication is likely and should lead to a better
understanding of the drug's pharmacological effects on motor disorders and pain.
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